AudioMedica News UK TACT2 trial confirms chemotherapy is highly effective in early beast cancer Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed SAN ANTONIO, TEXAS—The UK TACT2 trial, looking at over 4 000 patients with early breast cancer...
AudioMedica News Chronic myeloid leukaemia: third generation TKI, ponatinib, succeeds against the T 315 I mutation Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed ATLANTA, GEORGIA—A “third generation” tyrosine kinase inhibitor — ponatinib —...
AudioMedica News Younger than 35 with breast cancer: always consider neoadjuvant chemotherapy Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed SAN ANTONIO, TEXAS—Women with breast cancer under the age of 35 respond very well to neo-adjuvant...
AudioMedica News Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid? Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed ATLANTA, GEORGIA—Arsenic could play a key role in perfecting gentle but curative...
AudioMedica News New drug looks very promising in high risk chronic lymphocytic leukaemia Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed ATLANTA, GEORGIA—The new tyrosine kinase ibrutinib has shown “profound activity” in patients with...
AudioMedica News Local or regional breast cancer recurrences mandate adjuvant chemotherapy Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed SAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated...
AudioMedica News Lowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study finding Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed ATLANTA, GA—Solid confirmation of target...
AudioMedica News Breast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapse Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed SAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower...
AudioMedica News ASCO 2012 ANNUAL MEETING: Outgoing ASCO President Michael Link Comments On Key New Clinical Research Findings Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed CHICAGO—The outgoing president of ASCO, Dr Michael Link from...
AudioMedica News ASCO 2012 ANNUAL MEETING: Targeted Drug Afatinib Delays Progression of Advanced Lung Cancers, Particularly Those With Specific Genetic Mutations Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed CHICAGO—Findings from a Phase...
AudioMedica News ASCO 2012 ANNUAL MEETING: Resolving Long Debate, Study Finds Intermittent Hormonal Therapy Less Effective than Continuous Therapy in Certain Men With Advanced Prostate Cancer Play Episode Pause Episode 1x 00:00 / Subscribe RSS Feed...
STOCKHOLM—The first specialist in pediatric oncology ever to hold office as President of the American Society of Clinical Oncology, Dr Michael Link — Professor of Pediatrics at Stanford University School of Medicine — explains to Peter Goodwin how...